摘要:
Provided is a reactive emulsifier for emulsion polymerization, capable of enhancing stability during emulsion polymerization, avoiding a processing trouble by reducing foaming in a polymer dispersion, and improving the properties such as water resistance of a polymer film obtained from the polymer dispersion. An emulsifier for emulsion polymerization containing a compound represented by the following general formula (I) is used. In the general formula (I), R 0 represents an alkyl group having 1 to 4 carbon atoms, R 1 represents one or two types of groups selected from the groups shown below, R 2 represents hydrogen or a methyl group, D represents a polymerizable unsaturated group represented by the chemical formula D-1 or D-2 shown below, R 3 represents a hydrogen atom or a methyl group, m1 represents a number of 1 to 2, m2 represents a number of 1 to 4, m3 represents a number of 0 or 1, A represents an alkylene group or a substituted alkylene group having 2 to 4 carbon atoms, n represents an average addition mole number of alkylene oxide and represents a number in the range of 0 to 1,000, X represents a hydrogen atom or an anionic hydrophilic group selected from -(CH 2 ) a -SO 3 M, -(CH 2 ) b -COOM, -PO 3 M 2 , -P(Z)O 2 M, and -CO-CH 2 -CH(SO 3 M)-COOM, wherein a and b each represent a number of 0 to 4, Z represents a residue obtained by removing X from the general formula (I), and M represents a hydrogen atom, an alkali metal atom, an alkaline earth metal atom, an ammonium residue, or an alkanolamine residue.
摘要:
Compound of formula (I) wherein the dotted line is no bond or the dotted line together with the carbon-carbon bond represents a double bond; X and Y represent independently carbonyl, -CH2-, -CHMe-, or -C(Me)2-; and n and m are independently 0 or 1; with the proviso that if X is carbonyl either or both of n or m is 0, and their use as malodor counteractant. Furthermore, a process of their production and consumer products comprising them is described.
摘要:
The invention relates to substituted phenoxyacetic acids of formula (I), where the variables are as defined in claim 1, as useful pharmaceutical compounds for treating respiratory disorders, pharmaceutical compositions containing them, and processes for their preparation.
摘要:
A process for producing hydroxycarboxylic acids which comprises reacting an aldehyde compound, carbon monoxide and water in a reaction medium, said reaction being carried out in the presence of a crystalline aluminosilicate whose X-ray diffraction pattern shows at least five clear diffraction lines at a diffraction angle 20 of 7.9°±0.3°, 8.8°±0.3°, 23.2°±0.3°, 23.7°±0.3°, and 24.4°±0.3° while the concentration of the aldehyde compound in the reaction , mixture is maintained at not more than 15% by weight based on the total weight of the aldehyde compound and the reaction medium.
摘要:
This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis. Generally, the compounds and methods of the present invention increase the oral bioavailability and circulating concentrations of treprostinil when administered orally. Compounds of the present invention have formula (I).
摘要:
This invention pertains generally to prostacyclin analogs and methods for their use in promoting vasodilation, inhibiting platelet aggregation and thrombus formation, stimulating thrombolysis, inhibiting cell proliferation (including vascular remodeling), providing cytoprotection, preventing atherogenesis and inducing angiogenesis. Generally, the compounds and methods of the present invention increase the oral bioavailability and circulating concentrations of treprostinil when administered orally. Compounds of the present invention have formula (I).
摘要:
Disclosed herein are methods for treating type 2 diabetes, limiting development of type 2 diabetes, and treating a pre-diabetic state by administering to a subject in need thereof a GPBP inhibitor. Also disclosed herein are methods for diagnosing a pre-diabetic state and for diagnosing a propensity to develop type 2 diabetes by determining an amount of GPBP in a sample from a subject and comparing to control.